The mortality rate for pancreas malignant neoplasms in the US is expected to show a steady increase from 2024 to 2028, rising from 14.2 to 14.9 female deaths per 100,000 women. Considering that the value stood at 14.0 in 2023, the data indicates an annual increase in mortality rates. Year-on-year changes reflect a consistent increment of approximately 0.2 units, signifying a gradual increase, and the average annual growth rate (CAGR) over the five-year forecast period stands at around 1%.
Future trends to watch for include advancements in early detection and treatment methods that could alter mortality projections. Additionally, demographic shifts and lifestyle factors may impact future mortality trends, necessitating continuous updates in models for accurate forecasting.
